Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T25283 |
Cytochrome P450 2C9
Cyp2C9,Human cytochrome P450 2C9,Cytochrome P 450 2C9,S-Mephenytoin 4-hydroxylase |
||
Cytochrome P450 2C9 is a cytochrome P-450 subtype that possesses specificity for acidic xenobiotics. It oxidizes a wide range of important clinical drugs under the categories of nonsteroidal anti-inflammatory agents, anticoagulants, hypoglycemic agents, a | |||
T2393 |
Efavirenz
EFV,依非韦伦,DMP 266,依法韦仑,Sustiva,Stocrin,L-743726 |
HIV Protease; Reverse Transcriptase; Autophagy | Autophagy; Microbiology/Virology; Proteases/Proteasome |
Efavirenz (DMP 266) 是一种人类免疫缺陷病毒 1 非核苷类似物逆转录酶抑制剂。它也是一种野生型HIV-1 RT 抑制剂,Ki 为 2.93 nM,有效抑制 HIV-1 复制,IC95为 1.5 nM。 | |||
T2332 |
Elvitegravir
埃替格韦,GS-9137,EVG,D06677,JTK-303 |
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Elvitegravir (JTK-303) 是一种人类免疫缺陷病毒整合酶链转移抑制剂,作用于 HIV-1IIIB、HIV-2EHO 和 HIV-2ROD,IC50分别为 0.7 nM、2.8 nM 和 1.4 nM。 | |||
T39371 |
LKY-047
|
||
LKY-047, a derivative of Decursin, is a highly effective and specific reversible competitive inhibitor of cytochrome P45022J2 (CYP2J2), with an IC 50 value of 1.7 μM. LKY-047 does not display inhibitory activity against other human P450 enzymes including CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A. |